Cannabis matters? Treatment responses to increasing cannabis presentations in addiction services in England

Abstract

Aims To conduct a pilot project exploring how treatment providers understood the increasing demand of people presenting to services with cannabis related problems and how they responded to the demand for this type of treatment in the absence of an up to date evidencebase.Methods A knowledge exchange event involving treatment providers (n=30) from one region in the United Kingdom supplemented by qualitative interviews (n=8) and focus groups with drug treatment staff (n=5). A thematic analysis of this material was then conducted.Findings Five distinct themes emerged. First, numerous routes were identified into services for problematic cannabis users. Second, access to treatment for some groups is an issue. Third, the type of treatment offered varies considerably within and across services. Fourth, cannabis use was viewed as benign by many staff and clients with noticeable variations of risk. Finally, there is an acknowledgment that the there is an evolving connoisseurship associated with contemporary cannabis use whereby the client has increasing expertise in relation to contemporary cannabis consumption that has yet to fully filter through to the practice of treatment providers.Conclusions There appears to be a gap between treatment demand and evidence based treatment for cannabis related problems, so that while the trend in treatment demand continues to rise the translation of the evidence base into practise for effective treatment strategies has not kept pace with this demand. 2Cannabis matters? Treatment responses to increasing cannabis presentations in addiction services in England.

Changes in cannabis potency and first-time admissions to drug treatment: a 16-year study in the Netherlands

“…There are no approved pharmacotherapies for the treatment of cannabis use disorders, and psychosocial interventions have limited efficacy . The increase in cannabis admissions, alongside a lack of evidence-based interventions creates a significant challenge for treatment providers (Monaghan et al 2016). Clients entering specialist drug treatment with cannabis as a primary problem have shown the poorest treatment outcomes at 6 months (rates of abstinence and reduction in use) of all illicit drugs (NDTMS, 2014).…”

Secondary cannabis use among London drug treatment service clients

“…There is no definitive evidence that any specific treatment could be confidently suggested for problem cannabis use (Schettino, Leuschner, Tossmann, & Hoch, 2015) Independent Expert Working Group, 2017). Consequently, the lack of clear guidance creates discrepancies in how cannabis use is viewed by both clients and staff (Monaghan, Hamilton, Lloyd, & Paton, 2016).…”

Are we any closer to identifying a causal relationship between cannabis and psychosis?

“…Many users and healthcare professionals still view cannabis as relatively benign or think that individuals can't develop a physical or psychological dependency [31]. Globally an estimated 13 million people are dependent on the drug, accounting for two million disability adjusted life years, and the disorder is most prevalent in young people in higher income countries [30].…”